PROTARA THERAPEUTICS COMPLETES ENROLLMENT OF THE PHASE 2B OPEN-LABEL DOSE CONFIRMATION PHASE OF THE THRIVE-3 REGISTRATIONAL TRIAL OF IV CHOLINE CHLORIDE IN PATIENTS ON PARENTERAL SUPPORT

Reuters · 2d ago

Please log in to view news